(SYRA) Syra Health Common Stock - Ratings and Ratios

Syra Health Corp. is a US-based healthcare services company that offers a comprehensive suite of solutions aimed at improving behavioral and mental health, population health, and healthcare workforce management. The companys product portfolio includes Syrenity, a behavioral and mental health application that provides personalized interventions and therapy; SyraBot, a digital health tool that automates manual tasks and streamlines patient care; and CarePlus, a customizable platform for patient management and medical records. Syra Health also provides analytics as a service, medical communications, patient education, and healthcare training, as well as recruitment services for nurses and allied health professionals.

Syra Healths services cater to a diverse range of clients, including mental health hospitals, government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers. The companys solutions are designed to address the complex needs of the healthcare industry, from identifying and preventing mental health issues to improving patient outcomes and streamlining healthcare operations.

Analyzing the and , we can observe that Syra Health Corp.s stock has experienced significant volatility, with a 52-week high of $1.66 and a low of $0.05. The current price of $0.10 is below its 50-day and 200-day moving averages, indicating a downtrend. The Average True Range (ATR) of 0.04 represents a high level of volatility, with a percentage value of 39.64%. The companys market capitalization is approximately $1.07 million, with no reported P/E ratio, suggesting that the company is not yet profitable.

Based on the available data, a forecast for Syra Health Corp. can be made. Given the companys negative Return on Equity (RoE) of -103.53%, it is likely that the company will continue to experience financial challenges in the short term. However, if Syra Health can successfully execute its business plan and expand its customer base, the potential for growth exists. A possible trading strategy could involve monitoring the stocks price action and waiting for a breakout above the 50-day moving average of $0.17, with a potential target price of $1.00. Conversely, if the stock continues to decline, a stop-loss level could be set at $0.05 to limit potential losses.